Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, ...

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound ...

There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...